Evidence map›Paper›PMID 25288788›Full record

ArticleThe Journal of biological chemistry2014

High glucose forces a positive feedback loop connecting Akt kinase and FoxO1 transcription factor to activate mTORC1 kinase for mesangial cell hypertrophy and matrix protein expression.

Falguni Das, Nandini Ghosh-Choudhury, Nirmalya Dey, Amit Bera, Meenalakshmi M Mariappan, Balakuntalam S Kasinath, Goutam Ghosh Choudhury

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Falguni Dasthe Departments of Medicine and.
Nandini Ghosh-ChoudhuryPathology, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229 From the Veterans Affairs Research and Geriatric Research and.
Nirmalya Deythe Departments of Medicine and.
Amit Berathe Departments of Medicine and.
Meenalakshmi M Mariappanthe Departments of Medicine and.
Balakuntalam S Kasinaththe Departments of Medicine and From the Veterans Affairs Research and Geriatric Research and.
Goutam Ghosh Choudhurythe Departments of Medicine and From the Veterans Affairs Research and Geriatric Research and Education and Clinical Center, South Texas Veterans Health Care System, San Antonio, Texas 78229 and choudhuryg@uthscsa.edu.
South Texas Veterans Health Care System · US

Funding

Mechanism of Renal Cell Injury in DiabetesR01DK050190 · NIDDK · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI GHOSH CHOUDHURY, GOUTAM · 2004 to 2013
$2.3M
Mechanisms of Renal Cell InjuryI01BX000926 · VA · SOUTH TEXAS VETERANS HEALTH CARE SYSTEM · PI GHOSH CHOUDHURY, GOUTAM, SHARMA, KUMAR · 2011 to 2024
–
BLRD VA I01 BX000926NIDDK NIH HHS R01 DK050190NIDDK NIH HHS R01 DK50190
6 · The paper itself

Abstract

High glucose-induced Akt acts as a signaling hub for mesangial cell hypertrophy and matrix expansion, which are recognized as cardinal signatures for the development of diabetic nephropathy. How mesangial cells sustain the activated state of Akt is not clearly understood. Here we show Akt-dependent phosphorylation of the transcription factor FoxO1 by high glucose. Phosphorylation-deficient, constitutively active FoxO1 inhibited the high glucose-induced phosphorylation of Akt to suppress the phosphorylation/inactivation of PRAS40 and mTORC1 activity. In contrast, dominant negative FoxO1 increased the phosphorylation of Akt, resulting in increased mTORC1 activity similar to high glucose treatment. Notably, FoxO1 regulates high glucose-induced protein synthesis, hypertrophy, and expression of fibronectin and PAI-1. High glucose paves the way for complications of diabetic nephropathy through the production of reactive oxygen species (ROS). We considered whether the FoxO1 target antioxidant enzyme catalase contributes to sustained activation of Akt. High glucose-inactivated FoxO1 decreases the expression of catalase to increase the production of ROS. Moreover, we show that catalase blocks high glucose-stimulated Akt phosphorylation to attenuate the inactivation of FoxO1 and PRAS40, resulting in the inhibition of mTORC1 and mesangial cell hypertrophy and fibronectin and PAI-1 expression. Finally, using kidney cortices from type 1 diabetic OVE26 mice, we show that increased FoxO1 phosphorylation is associated with decreased catalase expression and increased fibronectin and PAI-1 expression. Together, our results provide the first evidence for the presence of a positive feedback loop for the sustained activation of Akt involving inactivated FoxO1 and a decrease in catalase expression, leading to increased ROS and mesangial cell hypertrophy and matrix protein expression.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsCatalaseCells, CulturedCell SizeDiabetes Mellitus, Type 1Dose-Response Relationship, DrugEnzyme ActivationFeedback, PhysiologicalFibronectinsForkhead Box Protein O1Forkhead Transcription FactorsGene ExpressionGlucoseImmunoblottingKidney CortexAdaptor Proteins, Signal TransducingAkt1s1 protein, ratCatalaseFibronectinsForkhead Box Protein O1Forkhead Transcription FactorsFoxo1 protein, ratGlucoseMechanistic Target of Rapamycin Complex 1Multiprotein ComplexesNerve Tissue ProteinsPhosphatidylinositol 3-KinasesPlasminogen Activator Inhibitor 1Proto-Oncogene Proteins c-aktReactive Oxygen SpeciesTOR Serine-Threonine KinasesAntioxidantCell SignalingDiabetesExtracellular MatrixGlucose

Identifiers

PMID25288788
PMCPMC4239622
OpenAlexW1996927477

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.